XBiotech Inc
NASDAQ:XBIT
Intrinsic Value
The intrinsic value of one
XBIT
stock under the Base Case scenario is
2.58
USD.
Compared to the current market price of 2.35 USD,
XBiotech Inc
is
Undervalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for XBiotech Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
XBiotech Inc
Balance Sheet Decomposition
XBiotech Inc
| Current Assets | 154.9m |
| Cash & Short-Term Investments | 152.9m |
| Receivables | 638k |
| Other Current Assets | 1.3m |
| Non-Current Assets | 23.8m |
| PP&E | 23.8m |
Free Cash Flow Analysis
XBiotech Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
XBiotech Inc
|
Revenue
|
0
USD
|
|
Operating Expenses
|
-36.5m
USD
|
|
Operating Income
|
-36.5m
USD
|
|
Other Expenses
|
8.4m
USD
|
|
Net Income
|
-28.2m
USD
|
XBIT Profitability Score
Profitability Due Diligence
XBiotech Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
XBiotech Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
XBIT Solvency Score
Solvency Due Diligence
XBiotech Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
XBiotech Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
XBIT Price Targets Summary
XBiotech Inc
Dividends
Current shareholder yield for
XBIT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
XBIT
stock under the Base Case scenario is
2.58
USD.
Compared to the current market price of 2.35 USD,
XBiotech Inc
is
Undervalued by 9%.